Cargando…

Encouraging results from phase 1/2 COVID-19 vaccine trials

Detalles Bibliográficos
Autores principales:	Bar-Zeev, Naor, Moss, William J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832572/ https://www.ncbi.nlm.nih.gov/pubmed/32702300 http://dx.doi.org/10.1016/S0140-6736(20)31611-1

Ejemplares similares

Expecting the unexpected with COVID-19 vaccines
por: Bar-Zeev, Naor, et al.
Publicado: (2021)

COVID-19 vaccines: early success and remaining challenges
por: Bar-Zeev, Naor, et al.
Publicado: (2020)

Human papillomavirus vaccination strategies for accelerating action towards cervical cancer elimination
por: Shet, Anita, et al.
Publicado: (2023)

Pragmatic trials to inform policy decisions and planning
por: Bar-Zeev, Naor, et al.
Publicado: (2023)

Population science with individual-level data make for better policies
por: Bar-Zeev, Naor, et al.
Publicado: (2021)

Encouraging vaccine uptake: lessons from behavioural science
por: Michie, Susan
Publicado: (2022)

Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential
por: Krause, Philip R, et al.
Publicado: (2020)

SARS-CoV-2 vaccination and phase 1 cancer clinical trials
por: Yap, Timothy A, et al.
Publicado: (2021)

COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
por: Putman, Michael, et al.
Publicado: (2022)

COVID-19 vaccine results might inform malaria vaccine strategies
por: Abeywickrema, Movin, et al.
Publicado: (2022)

Early-phase clinical trials in a pandemic: learning from the response to COVID-19
por: Horsley, Alex, et al.
Publicado: (2022)

COVID-19 vaccine trials should seek worthwhile efficacy
por: Krause, Philip, et al.
Publicado: (2020)

COVID-19 vaccines: breaking record times to first-in-human trials
por: Kim, Young Chan, et al.
Publicado: (2020)

A Higher Number of Covid19 Cases and Fatalities in Israel Phased With the Start of the Mass Vaccination
por: Boretti, Alberto
Publicado: (2021)

An immunological autobiography: my year as a COVID-19 vaccine trial participant
por: Kedl, Ross M.
Publicado: (2022)

COVID-19, vaccine hesitancy and child vaccination: Challenges from Brazil
por: Fernandez, Michelle, et al.
Publicado: (2022)

COVID-19 vaccination in patients with α1-antitrypsin deficiency
por: Yang, Chengliang, et al.
Publicado: (2021)

Leveraging Africa's preparedness towards the next phase of the COVID-19 pandemic
por: Senghore, Madikay, et al.
Publicado: (2020)

Suspending methotrexate for 2 weeks after COVID-19 vaccination
por: Coates, Laura C, et al.
Publicado: (2022)

COVID-19 vaccine hesitancy
por: Dubé, Eve, et al.
Publicado: (2022)

Incentives for COVID-19 vaccination
por: Brewer, Noel T., et al.
Publicado: (2022)

COVID-19 vaccinations for children
por: Mariatulqabtiah, Abdul Razak, et al.
Publicado: (2022)

Welcome evidence of vaccine impact in the Pacific
por: Saketa, Salanieta T, et al.
Publicado: (2020)

COVID-19 vaccines and kidney disease
por: Windpessl, Martin, et al.
Publicado: (2021)

Are COVID-19 vaccines safe in pregnancy?
por: Male, Victoria
Publicado: (2021)

Modelling vaccination strategies for COVID-19
por: Wagner, Caroline E., et al.
Publicado: (2022)

Waning effectiveness of COVID-19 vaccines
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Vaccine Verification in the COVID-19 World
por: Salmon, Daniel A., et al.
Publicado: (2021)

COVID-19 vaccines in patients with cancer
por: Trapani, Dario, et al.
Publicado: (2021)

COVID-19 vaccines and women's security
por: Harman, Sophie, et al.
Publicado: (2021)

COVID-19 vaccination encouraged by the EMA/ECDC
Publicado: (2021)

Measuring indirect effects of rotavirus vaccine in low income countries
por: Bennett, Aisleen, et al.
Publicado: (2016)

Redirected vaccine imprinting by co-administration of COVID-19 and influenza vaccines
por: Boyton, Rosemary J., et al.
Publicado: (2023)

COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England
por: Kirsebom, Freja C M, et al.
Publicado: (2022)

Ensuring global access to COVID-19 vaccines
por: Yamey, Gavin, et al.
Publicado: (2020)

Optimizing safety surveillance for COVID-19 vaccines
por: Chandler, Rebecca E.
Publicado: (2020)

Age and frailty in COVID-19 vaccine development
por: Andrew, Melissa K, et al.
Publicado: (2021)

The starting line for COVID-19 vaccine development
por: Lee, Nelson, et al.
Publicado: (2020)

Offline: Managing the COVID-19 vaccine infodemic
por: Horton, Richard
Publicado: (2020)

Optimism and caution for an inactivated COVID-19 vaccine
por: Rostad, Christina A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hatgbrlr5t7ifndv5iobq19cdd